000			01925 a2200493 4500
005			20250517132445.0
264		0	_c20170406
008			201704s 0 0 fre d
022			_a2213-0276
024	7		_a10.1016/j.lpm.2016.11.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aLaroche, Michel
245	0	0	_a[Effect of drugs for osteoporosis on cardiovascular diseases and effect of cardio vascular drugs on osteoporosis]. _h[electronic resource]
260			_bPresse medicale (Paris, France : 1983) _cMar 2017
300			_a159-164 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenergic beta-Antagonists _xpharmacokinetics
650	0	4	_aAntihypertensive Agents _xadverse effects
650	0	4	_aBone Density Conservation Agents _xadverse effects
650	0	4	_aCalcium _xadverse effects
650	0	4	_aCalcium, Dietary _xpharmacokinetics
650	0	4	_aCardiovascular Agents _xadverse effects
650	0	4	_aCardiovascular Diseases _xcomplications
650	0	4	_aDenosumab _xadverse effects
650	0	4	_aDiphosphonates _xadverse effects
650	0	4	_aDrug Interactions
650	0	4	_aHumans
650	0	4	_aHypercalcemia _xchemically induced
650	0	4	_aHypertension _xcomplications
650	0	4	_aMyocardial Infarction _xetiology
650	0	4	_aOsteoporosis _xcomplications
650	0	4	_aSodium Chloride Symporter Inhibitors _xpharmacokinetics
650	0	4	_aTeriparatide _xadverse effects
650	0	4	_aVitamin D _xpharmacokinetics
650	0	4	_aVitamin D Deficiency _xcomplications
700	1		_aDegboe, Yannick
700	1		_aBlain, Hubert
700	1		_aBreuil, Véronique
700	1		_aChapurlat, Roland
700	1		_aCortet, Bernard
700	1		_aSutter, Bruno
773	0		_tPresse medicale (Paris, France : 1983) _gvol. 46 _gno. 2 Pt 1 _gp. 159-164
856	4	0	_uhttps://doi.org/10.1016/j.lpm.2016.11.005 _zAvailable from publisher's website
999			_c26744648 _d26744648